{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,15]],"date-time":"2026-03-15T13:52:06Z","timestamp":1773582726742,"version":"3.50.1"},"reference-count":33,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2014,2,26]],"date-time":"2014-02-26T00:00:00Z","timestamp":1393372800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0089770","type":"journal-article","created":{"date-parts":[[2014,2,26]],"date-time":"2014-02-26T22:11:28Z","timestamp":1393452688000},"page":"e89770","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":9,"title":["Murine Experimental Autoimmune Encephalomyelitis Is Diminished by Treatment with the Angiogenesis Inhibitors B20-4.1.1 and Angiostatin (K1-3)"],"prefix":"10.1371","volume":"9","author":[{"given":"Carolyn J.","family":"MacMillan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolyn D.","family":"Doucette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordan","family":"Warford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne J.","family":"Furlong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David W.","family":"Hoskin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander S.","family":"Easton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,2,26]]},"reference":[{"key":"ref1","first-page":"505","article-title":"Vascular proliferation and angiogenesis in MS: clinical and pathogenic implications","volume":"60","author":"SK Ludwin","year":"2001","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.neulet.2009.12.059","article-title":"Increased blood vessel density and endothelial cell proliferation in multiple sclerosis cerebral white matter","volume":"470","author":"JE Holley","year":"2010","journal-title":"Neurosci Lett"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0896-8411(03)00139-2","article-title":"VEGF and vascular changes in chronic neuroinflammation","volume":"21","author":"SL Kirk","year":"2003","journal-title":"J Autoimmun"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jneuroim.2009.01.009","article-title":"VEGF and angiogenesis in acute and chronic MOG((35\u201355)) peptide induced EAE","volume":"209","author":"WA Roscoe","year":"2009","journal-title":"J Neuroimmunol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/1742-2094-7-95","article-title":"Angiogenesis is present in experimental autoimmune encephalomyelitis and pro-angiogenic factors are increased in multiple sclerosis lesions","volume":"7","author":"TJ Seabrook","year":"2010","journal-title":"J Neuroinflammation"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1097\/NEN.0b013e31823a8b6a","article-title":"Angiogenesis is regulated by angiopoietins during experimental autoimmune encephalomyelitis and is indirectly related to vascular permeability","volume":"70","author":"CJ MacMillan","year":"2011","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1097\/NEN.0b013e3182724831","article-title":"Bevacizumab diminishes experimental autoimmune encephalomyelitis by inhibiting spinal cord angiogenesis and reducing peripheral T cell responses","volume":"71","author":"CJ MacMillan","year":"2012","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1167\/iovs.07-1175","article-title":"Interaction between bevacizumab and murine VEGF-A: a reassessment","volume":"49","author":"L Yu","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s11481-009-9188-9","article-title":"Current views on the roles of Th1 and Th17 cells in experimental autoimmune encephalomyelitis","volume":"5","author":"M El-behi","year":"2010","journal-title":"J Neuroimmune Pharmacol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1074\/jbc.M508199200","article-title":"Cross-species vascular endothelial growth factor (VEGF)-blocking antibodies completely inhibit the growth of human tumor xenografts and measure the contribution of stromal VEGF","volume":"281","author":"WC Liang","year":"2006","journal-title":"J Biol Chem"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"29461","DOI":"10.1074\/jbc.271.46.29461","article-title":"Kringle domains of human angiostatin. Characterization of the anti-proliferative activity on endothelial cells","volume":"271","author":"Y Cao","year":"1996","journal-title":"J Biol Chem"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1073\/pnas.96.6.2811","article-title":"Angiostatin binds ATP synthase on the surface of human endothelial cells","volume":"96","author":"TL Moser","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1083\/jcb.152.6.1247","article-title":"Angiomotin: an angiostatin binding protein that regulates endothelial cell migration and tube formation","volume":"152","author":"B Troyanovsky","year":"2001","journal-title":"J Cell Biol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"6656","DOI":"10.1073\/pnas.131067798","article-title":"Endothelial cell surface F1-F0 ATP synthase is active in ATP synthesis and is inhibited by angiostatin","volume":"98","author":"TL Moser","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"6367","DOI":"10.1073\/pnas.95.11.6367","article-title":"Angiostatin gene transfer: inhibition of tumor growth in vivo by blockage of endothelial cell proliferation associated with a mitosis arrest","volume":"95","author":"F Griscelli","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"5579","DOI":"10.1073\/pnas.95.10.5579","article-title":"Angiostatin induces endothelial cell apoptosis and activation of focal adhesion kinase independently of the integrin-binding motif RGD","volume":"95","author":"L Claesson-Welsh","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1006\/bbrc.1999.0612","article-title":"Kringle 5 causes cell cycle arrest and apoptosis of endothelial cells","volume":"258","author":"H Lu","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"ref18","first-page":"4730","article-title":"Multiple forms of angiostatin induce apoptosis in endothelial cells","volume":"92","author":"R Lucas","year":"1998","journal-title":"Blood"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1006\/bbrc.1999.1486","article-title":"The tumor-suppressing ability of angiostatin protein resides within kringles 1\u20133","volume":"264","author":"NJ MacDonald","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1080\/10739680701410421","article-title":"Novel technique for estimating cerebrovascular permeability demonstrates capsazepine protection following ischemia-reperfusion","volume":"14","author":"V Gauden","year":"2007","journal-title":"Microcirculation"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.brainres.2009.08.076","article-title":"Modulation of blood-brain barrier permeability by neutrophils: in vitro and in vivo studies","volume":"1298","author":"SL Joice","year":"2009","journal-title":"Brain Res"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/0022-5193(78)90224-2","article-title":"A mathematical model for vasogenic brain edema","volume":"74","author":"SI Rapoport","year":"1978","journal-title":"J Theor Biol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1006\/mvre.1999.2188","article-title":"Microvessel organization and structure in experimental brain tumors: microvessel populations with distinctive structural and functional properties","volume":"58","author":"KE Schlageter","year":"1999","journal-title":"Microvasc Res"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1469-7793.1997.613bg.x","article-title":"Two components of blood-brain barrier disruption in the rat","volume":"503","author":"AS Easton","year":"1997","journal-title":"J Physiol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.semcancer.2003.09.018","article-title":"Antiangiogenic cancer therapy","volume":"14","author":"Y Cao","year":"2004","journal-title":"Semin Cancer Biol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1093\/jnen\/61.10.914","article-title":"Vascular endothelial growth factor is expressed in multiple sclerosis plaques and can induce inflammatory lesions in experimental allergic encephalomyelitis rats","volume":"61","author":"MA Proescholdt","year":"2002","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1365-3083.2006.01851.x","article-title":"Decreased expression of VEGF-A in rat experimental autoimmune encephalomyelitis and in cerebrospinal fluid mononuclear cells from patients with multiple sclerosis","volume":"64","author":"E Tham","year":"2006","journal-title":"Scand J Immunol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/nrd1381","article-title":"Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer","volume":"3","author":"N Ferrara","year":"2004","journal-title":"Nat Rev Drug Discov"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-008-0457-0","article-title":"Lymphatic drainage of the brain and the pathophysiology of neurological disease","volume":"117","author":"RO Weller","year":"2009","journal-title":"Acta Neuropathol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s11523-011-0204-7","article-title":"Cardiovascular toxicity of anti-angiogenic drugs","volume":"6","author":"G des Guetz","year":"2011","journal-title":"Target Oncol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1549-8719.2011.00147.x","article-title":"Anti-angiogenic therapy: concept to clinic","volume":"19","author":"RJ Young","year":"2012","journal-title":"Microcirculation"},{"key":"ref32","first-page":"4025","article-title":"Recombinant human angiostatin by twice-daily subcutaneous injection in advanced cancer: a pharmacokinetic and long-term safety study","volume":"9","author":"LV Beerepoot","year":"2003","journal-title":"Clin Cancer Res"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/annonc\/mdj055","article-title":"Recombinant human angiostatin (rhAngiostatin) in combination with paclitaxel and carboplatin in patients with advanced non-small-cell lung cancer: a phase II study from Indiana University","volume":"17","author":"A Kurup","year":"2006","journal-title":"Ann Oncol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0089770","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T05:12:02Z","timestamp":1540271522000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0089770"}},"subtitle":[],"editor":[{"given":"Thomas","family":"Forsthuber","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,2,26]]},"references-count":33,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2014,2,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0089770","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,26]]}}}